Navigation Links
PacificGMP Completes GMP Product Fill for Trius Therapeutics
Date:5/14/2008

SAN DIEGO, May 14 /PRNewswire/ -- PacificGMP, the leader in utilizing single-use bioprocessing for development and manufacturing for its client partners, announced today that it has completed a product fill under GMP (good manufacturing practices) standards for a Trius Therapeutics Phase I clinical trial.

"We are pleased to have worked closely with Trius on this GMP fill project, an effort that we were able to initiate quickly and complete within a narrow deadline," said Leigh N. Pierce, president of PacificGMP. "Although our client base consists of mainly biologics drug developers, PacificGMP has completed projects for a variety of other customers including small molecule drug developers like Trius, as well as academic institutions and diagnostics companies."

"PacificGMP successfully completed our GMP product fill and I appreciated their flexibility and willingness to work with us to get the job done in a timely and professional manner," said Jeffrey Barker, Director of Pharmaceutical Development for Trius Therapeutics.

About PacificGMP

PacificGMP is a contract manufacturing organization (CMO) and industry leader in utilizing single-use bioprocessing for development and manufacturing of biologics. Single-use technology eliminates the risk of cross-contamination, has fewer system requirements and significantly reduces the time required to initiate production. Benefits to clients include rapid project turnaround and the most cost effective solution in the industry. PacificGMP provides cGMP and non-GMP services ranging from cell line optimization, early process design, development and scale-up, to preclinical and clinical biologics manufacturing, purification and fill/finish. More information can be found by visiting the Company's web site at http://www.pacificGMP.com.

About Trius Therapeutics

Trius Therapeutics is discovering and developing innovative antibacterial
'/>"/>

SOURCE PacificGMP
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...re/ -- New research has found that the availabilit...T) scanner in an emergency room can significantly ...a potentially life-saving treatment. Results of th...NSMC)-Salem Hospital in Salem, Mass., will be pres...cal Society of North America (RSNA). , , "T...
(Date:12/1/2008)...RNewswire-USNewswire/ -- A study has found that po... for imaging the breast, is not affected by either...factors that limit the effectiveness of standard m...ll be presented today at the annual meeting of the... , "The ability of PEM to detect cancer does...
(Date:12/1/2008)...irstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: ...f the world,s leading medical journals, results of... experimental compound tasimelteon (VEC-162). The...elatonin agonist tasimelteon (VEC-162) for transie... controlled multicentre trials." Results are repor...
(Date:12/1/2008)...rgeGen has announced that an oral,presentation of...d clinical,trial of TG101348 in myeloproliferativ... American Society of Hematology (ASH) Meeting. , ...:, Title: A Phase I Study of TG... JAK2-Selective Inhibitor, in Patients with,...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Helix BioPharma Announces 2411 4 Million Private Placement 7982 1Helix BioPharma Announces 2411 4 Million Private Placement 7982 2New England Peptide Names Director of Chemical Development 7977 1New England Peptide Names Director of Chemical Development 7977 2LIAI launches new division to look at novel approaches to heart disease and inflammation 5131 1LIAI launches new division to look at novel approaches to heart disease and inflammation 5131 2LIAI launches new division to look at novel approaches to heart disease and inflammation 5131 3Kazak apple research key to preventing blue mold 5127 1Kazak apple research key to preventing blue mold 5127 2
...al Meeting of the American,Psychiatric Association... -- In adults with,major depressive disorder, addi...sulted in significant improvement in the primary,e...Scale (MADRS),Total Score. In this six-week, rando...the 160th Annual Meeting of the American,Psychiatr...
...ewswire/ -- Sirion Therapeutics,Inc., an ophthalm...day that it has received orphan drug designation f... anti-viral therapy,ganciclovir, for the treatmen...ently marketed by Laboratoires Thea in Europe unde... rights to,Virgan(R) for the United States from La...
Other Medicine Technology:Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2
(Date:12/2/2008)... At this year,s ASHP midyear meeting...rusted distributor of critical-care biopharmaceuti...model for supply chain integrity and demonstrate h...on to a new level. (Booth #1439) , ...,s ASHP midyear meeting, FFF Enterprises, the nati...
(Date:12/2/2008)... Marathon Health, a leading provider...s, has announced that New Balance, the athletic pr...velop, implement and manage onsite health clinics ...alance facilities in Maine , ...athon Health, a leading provider of onsite employe...
(Date:12/2/2008)... Does your over-the-phone interpreta... after you have completed the call? , ...2008 -- In the world of over-the-phone interpretat...OPI, a second over one minute can add up over the ...ding. When an organization employs an over-the-pho...
(Date:12/2/2008)... For many families, the problem with... Koch provides insight into how caregivers of agin...to the elder care experience. , ...or many families the stress of the holiday season ...t and elder care expert Esther Koch , founder of ...
Breaking Medicine News(10 mins):Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 2Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 3
...troke victims to bust blood clots may help treat s... according to a study published Monday. While tre... significantly in the last 25 years, it has largel...tbite, say the authors of the article published in...
...f an unarmed man on his wedding day, the New York ...halyzer tests after such shootings. Sean Bell, a 2... girlfriend, died in a hail of 50 bullets hours be...ar. Police opened fire on Bells car outside a top...
...on for cancer patients who have to spend weeks in ...ase of Nick Gall-Tomassen, aged 31, suffering fro...on time away from the ward. His backpack holds re...t into his body through a vein in his arm. Nick sa...
... Heart Center helps explain excessive body weight ...body weight is associated with a thickening of the...mping chamber. Known to physicians as left ventric...can lead to heart failure and rhythm problems. &#...
Other Medicine News:Health News:Frostbite can Be Treated by Bloodclot Drug 2Health News:Breathalyzer Tests for Cops Involved in Shootings 2Health News:Special Backpacks Provide Much Needed Relief for Cancer Patients 2
Avant E-Z Rack Premium Low Binding 10 l Microreach Pipet Tips are accurate, contamination free, and allow quantitative transfer of your samples without relying on silicone.
Ready to use: when presented in convenient, steady, Tipack racks, Diamond Tips are easy to pick up directly from the rack. To help prevent contamination, the 96 tips are loaded without manual interve
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
Ready to use: when presented in convenient, steady, Tipack racks, Diamond Tips are easy to pick up directly from the rack. To help prevent contamination, the 96 tips are loaded without manual interve
Medicine Products: